Family Offices Bet Big on Biotech in June
In June, family offices, which manage wealth for the ultra-rich, stepped up their investment game. They made 60 direct investments in companies, a jump from May's 47 deals. However, this is still a 40% drop compared to last year. Despite the overall decline, biotech and healthcare were hot topics, with nine deals in these sectors. One standout investment was in Anth...